WHO ICTRP trial
A Phase II, Randomized, Placebo-controlled, Observer-blind, Multi Center Study…
EUCTR2007-002712-25-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2007-002712-25-DE |
|---|---|
| Public title | A Phase II, Randomized, Placebo-controlled, Observer-blind, Multi Center Study on the Safety and Immunogenicity of Novartis Tetravalent Influenza Vaccine (containing both interpandemic strains and H5N1) in adults aged 18 years and above |
| Scientific title | A Phase II, Randomized, Placebo-controlled, Observer-blind, Multi Center Study on the Safety and Immunogenicity of Novartis Tetravalent Influenza Vaccine (containing both interpandemic strains and H5N1) in adults aged 18 years and above |
| Primary sponsor | Novartis Vaccines and Diagnostics GmbH & Co. KG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Conditions | Avian Influenza |
| Interventions | Product Name: Novartis Tetravalent Influenza Vaccine Pharmaceutical Form: Suspension for injection Other descriptive name: Influenza virus surface antigens A/Vietnam/1194/2004 (H5N1 Clade 1) Concentration unit: µg microgram(s) Concentration… |
| Registration date | Feb 8, 2007 |
| Secondary IDs | V101P1 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: